Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

ZOLL to display resuscitation technology, temperature management solutions at AHA 2011

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that 27 scientific presentations related to ZOLL products and technology are scheduled to be presented during the American Heart Association (AHA) 2011 Resuscitation Science Symposium (ReSS) and Scientific Sessions.

10 Nov 2011

Treatments can help most HCM patients

Most of the 600,000 Americans with hypertrophic cardiomyopathy (HCM) -- a genetic heart muscle disease -- can live normal life spans, according to the first science-based guideline for diagnosing and treating this disorder.

9 Nov 2011

Maryland anesthesiologist named 2011 Researcher of the Year

Often on the mind of Gary Fiskum, PhD, are the more than 250,000 people in the U.S. who get resuscitated from cardiac arrest each year, the 6 million living with traumatic brain injuries, and the wounded warriors whose brain whose brains sustain enormous G-forces from roadside bombs in the war zone.

9 Nov 2011

Edwards Lifescience receives FDA approval for Sapien Transcatheter Heart Valve

The U.S. Food and Drug Administration today approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery.

3 Nov 2011

ADHD drugs don’t raise risk for heart attacks or stroke: Study

Drugs known as stimulants, that are used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes or sudden death, U.S. researchers said on Monday. This study finding should reassure millions of parents whose children take the drugs.

2 Nov 2011

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.

31 Oct 2011

More than 50,000 patients at high risk of SCA have been prescribed ZOLL's LifeVest

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest Wearable Defibrillator.

29 Oct 2011

UCSD unveils Center for the Future of Surgery

Every year, millions of patients undergo lifesaving surgeries. The outcome of each procedure is driven by dynamic factors such as the patient's health, drugs and instruments used, team communication, and the wisdom of the surgeon's hand. To advance safety and innovation in today's operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest state-of-the art facility in the nation dedicated to catalyzing novel surgical technologies, techniques and teaching methods.

19 Oct 2011

Jersey Shore completes first procedure with Abiomed's Impella 2.5 heart pump

Jersey Shore University Medical Center announces the completion of its first procedure with Abiomed's Impella 2.5 heart pump. Jersey Shore is the first and only regional hospital to include the World's Smallest Heart Pump in their portfolio of treatment options to assist critically ill heart patients.

19 Oct 2011

Experts from CHOP address American Academy of Pediatrics annual meeting

Numerous experts from The Children's Hospital of Philadelphia will be addressing their colleagues at this year's annual meeting of the American Academy of Pediatrics on topics as varied as vaccine education, fetal surgery, sudden cardiac arrest, and sports injuries, among others.

15 Oct 2011

GFAP protein levels can help identify HIE in newborns

Johns Hopkins researchers have discovered that increased blood levels of a protein specific to central nervous system cells that are vital to the brain's structure can help physicians identify newborns with brain injuries due to lack of oxygen.

14 Oct 2011

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-moving mist to deliver the same active ingredients of COMBIVENT Inhalation Aerosol in a metered dose inhaler.

10 Oct 2011

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.

7 Oct 2011

Over 13,000 youth to receive cardiac screenings in Oct.

During National Sudden Cardiac Arrest Awareness (SCA) Month in October, thirteen organizations from across the nation are participating in Screen Across America, a national initiative that provides cardiac screenings to youth ages 5-24. The goal of this collaborative effort is to increase awareness about Sudden Cardiac Arrest in youth and the importance of cardiac screenings and early detection in saving young lives.

3 Oct 2011

Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation

A pill from Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big clinical trial of it shows. It is unclear whether it will ever reach the market in the U.S. or Western Europe though.

29 Sep 2011

Patients with chronic conditions likely to change their preferences for CPR

Patients with chronic conditions are likely to change their preferences for receiving emergency procedures in the event of cardiac arrest, according to new findings.

27 Sep 2011

Cambridge Heart enters agreement with EO Medical for MTWA technology

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.

22 Sep 2011

Poor neighborhoods linked to higher risk of out-of-hospital cardiac deaths

People living in poor neighborhoods are at higher risk of dying of heart disease outside a hospital than are people who live in wealthier neighborhoods, research suggests.

21 Sep 2011

Hasbro Children's Hospital joins Pediatric Emergency Care Applied Research Network

The emergency medicine department at Hasbro Children's Hospital has received a grant that will support its participation in the Pediatric Emergency Care Applied Research Network (PECARN). This is the nation's first federally funded pediatric research network focused on the prevention and management of acute illnesses and injuries in children of all ages.

8 Sep 2011

Two ROC trials evaluate new strategies for CPR following cardiac arrest

Researchers with the Resuscitation Outcomes Consortium, which includes the University of Alabama at Birmingham, report Sept. 1 in the New England Journal of Medicine on the first two large-scale ROC trials. Both trials were evaluating new strategies for cardiopulmonary resuscitation following cardiac arrest.

2 Sep 2011